A Collaborative CRO Partnership
Delivering Full Service Clinical Trial Execution
Avetra partners with sponsors to support the planning and execution of clinical trials across a range of therapeutic areas. Our team works closely with sponsor organizations to coordinate study activities, support research sites, and maintain clear communication throughout the clinical trial lifecycle.
Avetra works closely with sponsor teams to support clinical trial execution through transparent communication and coordinated operational support. Our approach emphasizes collaboration with sponsors, investigators, and study partners to ensure that study objectives remain aligned throughout the trial. This collaborative model allows sponsors to remain actively engaged in the progress of their clinical programs.
Flexible Support for Clinical Development
Clinical development programs often evolve as new data and operational needs emerge. Avetra’s service model is designed to support sponsors across different stages of clinical development, whether coordinating individual study components or supporting broader clinical programs.
Avetra works with a range of sponsor organizations, including emerging biotechnology companies and growing development programs. Our flexible structure allows sponsors to access experienced clinical operations leadership while maintaining close collaboration with their internal teams.
Integrated Clinical & Laboratory Execution
Biospecimen workflows are often one of the most common sources of delay and miscommunication. By embedding laboratory oversight directly into clinical operations, sample handling, documentation, and data reconciliation are coordinated from the start.
There is one operational structure overseeing both patient-facing and laboratory-facing processes. That alignment reduces unnecessary handoffs and supports consistent documentation across systems.
Agile by design. Structured to support complex studies while maintaining close working relationships and direct access to decision-makers.
Data Quality That Supports Regulatory Confidence
Development programs must withstand regulatory review. Data capture, documentation practices, and quality oversight are aligned with:
- ICH E6 (GCP)
- Applicable GxP standards
- FDA and EMA expectations
- Regional regulatory authority requirements
Oversight includes:
- Structured data management planning
- Ongoing documentation review
- Risk-based quality management
- Inspection readiness preparation
- Audit support
Data integrity is addressed continuously rather than retroactively.
Clear Governance Without Excess Layers
Sponsors benefit from defined timelines, direct communication pathways, and visible decision structures. Milestones are established early, and reporting remains structured without becoming burdensome.
Governance typically includes:
- A clear operating cadence (status, risks, decisions)
- Defined escalation pathways
- Cross-functional alignment across clinical, regulatory, data, safety, and lab functions
Built for Programs That Require Coordination
Whether supporting early-phase development, biomarker-driven programs, multi-site trials, or large validation efforts, the operational structure remains consistent. The goal is simple: coordinated execution that reduces friction and supports defensible results.
